Arash Akmal, PHARMD is a
Pharmacy - Community/retail Pharmacy based in Glendale, California. Arash Akmal is licensed to practice in California (license number PHY50931) and his current practice location is
3452 Country Club Dr, Glendale, California. He can be reached at his office (for appointments etc.) via phone at
(310) 463-7326.
NPI number for Arash Akmal is 1033492368 and his current mailing address is 3452 Country Club Dr, Glendale, California. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1033492368.
Healthcare Provider's Profile
Full Name | Arash Akmal |
---|
Gender | Male |
---|
Speciality | Pharmacy - Community/retail Pharmacy |
---|
Location | 3452 Country Club Dr, Glendale, California |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
NPI Data:
- NPI Number: 1033492368
- Provider Enumeration Date: 09/22/2011
- Last Update Date: 04/23/2013
Medical Identifiers
Medical identifiers for Arash Akmal such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1033492368 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
183500000X | Pharmacist | 60763 (California) | Secondary |
3336C0003X | Pharmacy - Community/retail Pharmacy | PHY50931 (California) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Arash Akmal is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Arash Akmal, PHARMD 3452 Country Club Dr, Glendale, CA 91208-1154 Ph: (310) 463-7326 | Arash Akmal, PHARMD 3452 Country Club Dr, Glendale, CA 91208-1154 Ph: (310) 463-7326 |
Reviews and Comments